Biofrontera confirms financing need
June 30, 2020 08:30 ET
|
Biofrontera AG
Leverkusen, Germany, June 30, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today confirmed the...
Biofrontera announces conference call to be held on April 21, 2020 to discuss full year 2019 financial results
April 09, 2020 12:30 ET
|
Biofrontera AG
Leverkusen, Germany, April 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...
European Medicines Agency recommends indication expansion of Ameluz® for treatment of actinic keratoses on the extremities and trunk/neck
February 03, 2020 05:45 ET
|
Biofrontera AG
Leverkusen, Germany, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...
Biofrontera reports preliminary unaudited sales revenue for the first nine months of 2019
October 10, 2019 05:15 ET
|
Biofrontera AG
Leverkusen, Germany, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical...
Biofrontera to present at the Baader Investment Conference
September 17, 2019 09:45 ET
|
Biofrontera AG
Leverkusen, Germany, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced that Prof....
Annual General Meeting of Biofrontera AG: Biofrontera Management Board approved by large majority
July 11, 2019 05:23 ET
|
Biofrontera AG
Leverkusen, Germany, July 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...
All Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their shares
June 21, 2019 03:30 ET
|
Biofrontera AG
The Management Board intends to tender all personally held Biofrontera AG shares to Maruho Deutschland GmbHThe Management Board intends to help Maruho Deutschland GmbH to successfully complete its...
Biofrontera Reports First Quarter 2019 Financial Results
May 29, 2019 03:11 ET
|
Biofrontera AG
Leverkusen, Germany, May 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...